Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-013804
Filing Date
2025-06-05
Accepted
2025-06-05 16:06:05
Documents
1
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6050
  Complete submission text file 0001641172-25-013804.txt   7773
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Issuer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 6734 TALMADGE LANE DALLAS TX 75230
Business Address
Parnell Winfred (Reporting) CIK: 0001979704 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34810 | Film No.: 251027125